Skip to main content

end-user needs

You are here

Home > Tags > End User Needs

AI app could help diagnose HIV more accurately

 Pioneering technology developed by UCL and Africa Health Research Institute (AHRI) researchers could transform the ability to accurately interpret HIV test results, particularly in low- and middle-income countries.

Academics from the London Centre for Nanotechnology at UCL and AHRI used deep learning (artificial intelligence/AI) algorithms to improve health workers’ ability to diagnose HIV using lateral flow tests in rural South Africa.

Digital revolution for people with sexually transmitted infections

World-renowned sexual health experts are behind a new NHS digital revolution for people with sexually transmitted infections (STIs) using a new automated online consultation giving patients 24-hour access to medical care.

A team of scientists, led by Glasgow Caledonian University Prof of HIV and Sexual Health, and i-sense member, Prof Claudia Estcourt, have launched an ambitious five-year research project to develop a new NHS digital platform to improve care for people with STIs.

Using lasers to rapidly detect antimicrobial resistance

Antibiotic resistence is a growing global concern and major threat to human health.

The standard method used to detect resistance in bacteria, known as phenotypic antibiotic sensitivity testing, monitors bacterial growth over about 12 – 24 hours and is therefore a slow process. New rapid methods for antibiotic sensitivity testing are urgently needed to improve antibiotic stewardship.

Digital technologies and data privacy in the COVID-19 pandemic

A Nature Medicine review, led by researchers in the EPSRC funded i-sense project, looks at how digital technologies have been mobilised for a global public health response to COVID-19 and the associated concerns with privacy and efficacy in an evolving digital world.

Lead author and Director of i-sense EPSRC IRC at UCL, Prof Rachel McKendry said: “Our review shows that digital technologies have an important role in a comprehensive response to the pandemic, alongside conventional measures.”

Meet our researchers - Dr Leah Frenette

Dr Leah Frenette is a Postdoctoral Research Associate in Prof Molly Stevens group at Imperial College London. Her research area and insterests cover nanomaterials chemistry, developing new nanoparticles and investigating how they can be used in infectious disease diagnostics. In this short interview, Leah shares with us her career so far and how she's adapted her research during the COVID-19 lockdown period. 

Go local: the key to COVID-19 lockdown release

Pandemics, such as COVID-19, are usually assumed to spread rapidly within the population. In reality, the population is more heterogeneous with regard to risk, and there will be large variation on the basis of geography, workplace and other key factors.

Analysing data on a national level therefore risks hiding this heterogeneity and compromises the most effective public health response. New analysis from i-sense researchers at University College London suggests COVID-19 has such diverse effects on the different local authorities in the UK.

Pages